Psychotropic Drug Use in Children and Adolescents Before and During the COVID-19 Pandemic

JAMA Pediatr. 2022 Mar 1;176(3):318-320. doi: 10.1001/jamapediatrics.2021.5634.

Authors

Christine Leong¹, Laurence Y Katz¹, James M Bolton¹, Murray W Enns¹, Joseph Delaney¹, Qier Tan², Jitender Sareen¹

Affiliations

¹ University of Manitoba, Winnipeg, Manitoba, Canada.
² Manitoba Centre for Health Policy, Winnipeg, Manitoba, Canada.

Abstract

This cross-sectional study examines incidence of prevalence psychotropic drug use in Manitoban children before and during the COVID-19 pandemic.

MeSH terms

Adolescent
COVID-19 / epidemiology
COVID-19 / prevention & control*
Child
Cross-Sectional Studies
Female
Humans
Incidence
Male
Manitoba / epidemiology
Mental Disorders / drug therapy*
Mental Disorders / epidemiology
Mental Disorders / psychology
Pandemics
Prevalence
Psychotropic Drugs / therapeutic use*
SARS-CoV-2

Substances

Psychotropic Drugs